#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA3734216	F	Increase in insulin release in mouse BetaTC6 cells assessed as relative insulin release activity at 10 uM incubated for 2 to 4 hrs by FRET based HTRF assay relative to sunitinib	Mus musculus	355	ALA3727361	cell-based format	Patent Bioactivity Data
2.	ALA3734218	A	Cytotoxic activity against mouse C2C12 cells assessed as inhibition of cell proliferation of at 2 to 10 uM incubated for 72 hrs by MTT assay	Mus musculus	9	ALA3727361	cell-based format	Patent Bioactivity Data
3.	ALA3734219	A	Cytotoxic activity against mouse BetaTC6 cells assessed as inhibition of cell proliferation at 2 to 10 uM incubated for 72 hrs by MTT assay	Mus musculus	2	ALA3727361	cell-based format	Patent Bioactivity Data
4.	ALA3734220	B	Inhibition of Scyl1 in mouse BetaTC6 cells assessed as increase in insulin release at 5 uM incubated for 2 hrs by ELISA	Mus musculus	7	ALA3727361	cell-based format	Patent Bioactivity Data
5.	ALA3734221	B	Inhibition of Scyl1 in mouse BetaTC6 cells assessed as increase in insulin release at 2 to 10 uM incubated for 2 hrs in presence of high glucose media by ELISA	Mus musculus	5	ALA3727361	cell-based format	Patent Bioactivity Data
6.	ALA3734222	A	Effect on insulin release in mouse BetaTC6 cells assessed as ratio of insulin release incubated for 2 hrs in presence of low glucose media by ELISA relative to DMSO	Mus musculus	7	ALA3727361	cell-based format	Patent Bioactivity Data
7.	ALA3734256	B	Inhibition of Scyl1 in mouse C2C12 cells assessed as insulin-dependent increase of 2-NBDG uptake (Rvb = 11.78 +/- 1.22%)	Mus musculus	1	ALA3727361	cell-based format	Patent Bioactivity Data
8.	ALA3734259	A	Cytotoxic activity against mouse C2C12 cells assessed as inhibition of cell proliferation of at 2 uM incubated for 72 hrs by MTT assay	Mus musculus	3	ALA3727361	cell-based format	Patent Bioactivity Data
9.	ALA3734260	B	Inhibition of Scyl1 in mouse BetaTC6 cells assessed as reduction in increase in insulin release at 5 uM incubated for 2 hrs by ELISA	Mus musculus	1	ALA3727361	cell-based format	Patent Bioactivity Data
10.	ALA3734261	B	Inhibition of Scyl1 in mouse BetaTC6 cells assessed as reduction in increase in insulin release incubated for 2 hrs by ELISA	Mus musculus	1	ALA3727361	cell-based format	Patent Bioactivity Data
11.	ALA3734262	B	Inhibition of Scyl1 in mouse BetaTC6 cells assessed as ratio of insulin release at 2 uM incubated for 2 hrs by ELISA relative to DMSO (Rvb = 1 No_unit)	Mus musculus	5	ALA3727361	cell-based format	Patent Bioactivity Data
12.	ALA3734263	B	Inhibition of Scyl1 in mouse BetaTC6 cells assessed as ratio of insulin release at 5 uM incubated for 2 hrs by ELISA relative to DMSO (Rvb = 1 No_unit)	Mus musculus	5	ALA3727361	cell-based format	Patent Bioactivity Data
13.	ALA3734264	B	Inhibition of Scyl1 in mouse BetaTC6 cells assessed as ratio of insulin release at 10 uM incubated for 2 hrs by ELISA relative to DMSO (Rvb = 1 No_unit)	Mus musculus	5	ALA3727361	cell-based format	Patent Bioactivity Data
14.	ALA3734265	B	Inhibition of Scyl1 in mouse C2C12 cells assessed as increase in 2-NBDG uptake at 5 uM after 1 hr relative to DMSO	Mus musculus	7	ALA3727361	cell-based format	Patent Bioactivity Data
15.	ALA3734266	B	Inhibition of Scyl1 in mouse BetaTC6 cells assessed as increase in 2-NBDG uptake at 5 uM after 1 hr relative to DMSO	Mus musculus	7	ALA3727361	cell-based format	Patent Bioactivity Data
16.	ALA3734277	B	Inhibition of Scyl1 in mouse C2C12 cells assessed as insulin release by ELISA	Mus musculus	1	ALA3727361	cell-based format	Patent Bioactivity Data